Sentinel node-assisted neck dissection in advanced oral squamous cell carcinoma-A new protocol for staging and treatment
- PMID: 37084007
- PMCID: PMC10278494
- DOI: 10.1002/cam4.5966
Sentinel node-assisted neck dissection in advanced oral squamous cell carcinoma-A new protocol for staging and treatment
Abstract
Background: Sentinel lymph node biopsy (SLNB) is used to improve the staging of and guide treatment in patients with early-stage T1-T2 N0 oral squamous cell carcinoma (OSCC). The role of sentinel nodes (SNs) and the use of SN-technique in advanced OSCC (T3-T4 and/or N+) remain to be evaluated. This study investigates the nodal drainage and the rate of positive SNs (SNs+) in all stages of OSCC.
Materials and methods: In total, 85 patients with T1-T4 OSCC diagnosed 2019-2021 were included. We used a prolonged interval between peritumoral injection of radionuclide and SPECT-CT to include all SNs.
Results: Patients with advanced OSCC presented a higher proportion of contralateral lymphatic drainage and a higher rate of SN+ compared to patients with early-stage disease. T3-T4 and N+ tumors presented a tendency for a higher rate of contralateral lymphatic drainage compared to T1-T2 and N0 tumors (p = 0.1). The prevalence of positive nodes (SNs+) was higher among patients with advanced disease, T3-T4 versus T1-T2 (p = 0.0398).
Conclusion: SN-assisted ND enables identification and removal of all SNs + and has the potential for more accurate staging and could possibly give prognostic advantages regarding regional recurrence for all OSCC patients, especially among those with advanced disease. The precise localization of the SNs + also suggests that a more individualized ND approach might be possible in the future even for patients with advanced OSCC.
Keywords: head and neck cancer; metastases; neck dissection; oral squamous cell carcinoma; sentinel node biopsy.
© 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Sentinel node biopsy for oral cancer: A prospective multicenter Phase II trial.Auris Nasus Larynx. 2017 Jun;44(3):319-326. doi: 10.1016/j.anl.2016.07.008. Epub 2016 Aug 3. Auris Nasus Larynx. 2017. PMID: 27496008 Clinical Trial.
-
Distribution pattern and pathologic analysis of metastatic sentinel and non-sentinel lymph nodes in lymphatic basin dissection for clinical T2/T3 oral cancer with clinical N0 status.Auris Nasus Larynx. 2022 Aug;49(4):680-689. doi: 10.1016/j.anl.2021.11.010. Epub 2021 Dec 9. Auris Nasus Larynx. 2022. PMID: 34895941
-
Effectiveness of sentinel lymph node scintigraphy and intraoperative gamma probing with gold standard elective neck dissection in patients with N0 oral squamous cell cancers.Nucl Med Commun. 2019 Nov;40(11):1138-1147. doi: 10.1097/MNM.0000000000001090. Nucl Med Commun. 2019. PMID: 31568193 Clinical Trial.
-
What is the role of sentinel lymph node biopsy in the management of oral cancer in 2020?Eur Arch Otorhinolaryngol. 2021 Sep;278(9):3181-3191. doi: 10.1007/s00405-020-06538-y. Epub 2020 Dec 28. Eur Arch Otorhinolaryngol. 2021. PMID: 33369691 Free PMC article. Review.
-
Diagnostic yield of sentinel lymph node biopsy in oral squamous cell carcinoma T1/T2-N0: systematic review and meta-analysis.Int J Oral Maxillofac Surg. 2021 Oct;50(10):1271-1279. doi: 10.1016/j.ijom.2021.01.020. Epub 2021 Feb 16. Int J Oral Maxillofac Surg. 2021. PMID: 33602650
Cited by
-
A novel near-infrared EGFR targeting probe for metastatic lymph node imaging in preclinical mouse models.J Nanobiotechnology. 2023 Sep 22;21(1):342. doi: 10.1186/s12951-023-02101-z. J Nanobiotechnology. 2023. PMID: 37736720 Free PMC article.
-
Six-month mortality has decreased for patients with curative treatment intent for head and neck cancer in Sweden.PLoS One. 2024 Apr 16;19(4):e0296534. doi: 10.1371/journal.pone.0296534. eCollection 2024. PLoS One. 2024. PMID: 38625920 Free PMC article.
References
-
- Global Burden of Disease Cancer C , Kocarnik JM, Compton K, Dean FE, et al. Cancer incidence, mortality, years of life lost, years lived with disability, and disability‐adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019. JAMA Oncologia. 2022;8:420‐444. - PMC - PubMed
-
- Annertz K, Anderson H, Palmer K, Wennerberg J. The increase in incidence of cancer of the tongue in the Nordic countries continues into the twenty‐first century. Acta Otolaryngol. 2012;132:552‐557. - PubMed
-
- Tota JE, Anderson WF, Coffey C, et al. Rising incidence of oral tongue cancer among white men and women in the United States, 1973–2012. Oral Oncol. 2017;67:146‐152. - PubMed
-
- Ng JH, Iyer NG, Tan MH, Edgren G. Changing epidemiology of oral squamous cell carcinoma of the tongue: a global study. Head Neck. 2017;39:297‐304. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical